Company news
Bio-techne Corp (NASDAQ:TECH) news
Bio-techne Corp news releases on 6ix. Latest, Sep 23, 2026: Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
Press releases & updates
Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
September 23, 2026
Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration
September 22, 2026
Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals
September 1, 2026
Bio-Techne Corrects Dividend Announcement
August 13, 2026
Bio-Techne Releases Fourth Quarter Fiscal 2026 Results
August 12, 2026
Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio
July 8, 2026
Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets
June 25, 2026
Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization
June 4, 2026
Bio-Techne Releases Third Quarter Fiscal 2026 Results
May 6, 2026
Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference
May 4, 2026
Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
April 16, 2026
Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results
April 13, 2026
Bio-Techne Advances Spatial Biology with Modular Expansion of COMET Suite
March 26, 2026
Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite
March 24, 2026
Evolve Announces March 2026 Distributions for UltraYield ETFs and Certain Evolve Funds
March 18, 2026
Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories
February 16, 2026
Bio-Techne Announces Changes to its Leadership Team
February 11, 2026
Bio-Techne Releases Second Quarter Fiscal 2026 Results
February 4, 2026
Bio-Techne Declares Dividend
February 4, 2026
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
February 2, 2026
Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers
January 28, 2026
Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results
January 19, 2026
Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference
December 22, 2025
Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology
December 10, 2025
Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis
December 8, 2025
Evolve Announces Estimated Annual Distributions for Certain Evolve Funds
December 2, 2025
Bio-Techne to Present at Upcoming Investor Conferences
November 24, 2025
Bio-Techne Licenses AI-Designed NovoBody Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio
November 19, 2025
Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio
November 17, 2025
Bio-Techne Releases First Quarter Fiscal 2026 Results
November 4, 2025
BIO-TECHNE DECLARES DIVIDEND
November 4, 2025
AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients
November 3, 2025
ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics
November 3, 2025
Bio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
October 27, 2025
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National Hospital
October 23, 2025
Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results
October 14, 2025
Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
October 8, 2025
Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications
September 25, 2025
Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report
September 23, 2025
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
September 15, 2025
CONMED Corporation Adds Kim Kelderman to its Board of Directors
September 9, 2025
ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory
August 14, 2025
Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
August 5, 2025
Bio-Techne Announces Exosome Diagnostics Divestiture
August 4, 2025
ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering
July 31, 2025
Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results
July 16, 2025
Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
July 14, 2025
Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
July 13, 2025
Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
June 23, 2025
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
June 10, 2025